title: Is there any evidence that the Trans Pacific Partnership Agreement will threaten access to affordable medicines and health equity in New Zealand?
authors.affiliation: Wonder Drug Consulting, Sydney, Australia. Electronic address: wonderdrug@optusnet.com.au.
authors.forename: Michael
authors.initials: M
authors.lastname: Wonder
authors.affiliation: School of Population Health, University of Auckland, Auckland, New Zealand.
authors.forename: Richard
authors.initials: R
authors.lastname: Milne
mesh_terms: D003132:Commerce / Q000331:legislation & jurisprudence*; D016527:Drug Costs / Q000706:statistics & numerical data*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D005102:Health Expenditures / Q000706:statistics & numerical data*; D006297:Health Services Accessibility; D006801:Humans; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D004364:Pharmaceutical Preparations / Q000191:economics*
chemical_list: D004364:Pharmaceutical Preparations